Achieve Life Sciences (ACHV) Misses Q3 EPS by 22c

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($1.35), $0.22 worse than the analyst estimate of ($1.13).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Worried the AI trade has gone too far? Evercore likes these 4 stocks